chrX-153740711-G-C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000033.4(ABCD1):c.1772G>C(p.Arg591Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R591Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000033.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000033.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ABCD1 | NM_000033.4 | MANE Select | c.1772G>C | p.Arg591Pro | missense | Exon 7 of 10 | NP_000024.2 | ||
| ABCD1 | NM_001440747.1 | c.2072G>C | p.Arg691Pro | missense | Exon 8 of 11 | NP_001427676.1 | |||
| PLXNB3-AS1 | NR_199693.1 | n.90-2133C>G | intron | N/A |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ABCD1 | ENST00000218104.6 | TSL:1 MANE Select | c.1772G>C | p.Arg591Pro | missense | Exon 7 of 10 | ENSP00000218104.3 | ||
| PLXNB3-AS1 | ENST00000434284.1 | TSL:3 | n.72-2133C>G | intron | N/A | ||||
| ABCD1 | ENST00000443684.2 | TSL:3 | n.*107G>C | downstream_gene | N/A |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Adrenoleukodystrophy Pathogenic:2
Variant summary: ABCD1 c.1772G>C (p.Arg591Pro) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. The variant was absent in 182606 control chromosomes. c.1772G>C has been observed in individuals affected with Adrenoleukodystrophy (e.g. Horn_2013, Kemp_2001). These data indicate that the variant may be associated with disease. A different variant affecting the same codon has been classified as likely pathogenic/pathogenic by our lab (c.1772G>A, p.Arg591Gln), supporting the critical relevance of codon 591 to ABCD1 protein function. One publication reports absent ABCD1 protein product in a Adrenoleukodystrophy patient (e.g. Kemp_2001). The following publications have been ascertained in the context of this evaluation (PMID: 23419472, 11748843). ClinVar contains an entry for this variant (Variation ID: 2737418). Based on the evidence outlined above, the variant was classified as likely pathogenic.
This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 591 of the ABCD1 protein (p.Arg591Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with X-linked adrenoleukodystrophy (PMID: 23419472). ClinVar contains an entry for this variant (Variation ID: 2737418). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCD1 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg591 amino acid residue in ABCD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7668254, 10190819, 12175782, 19129531, 22280810, 23566833, 24154795, 28503596). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at